摘要
PURPOSE： Fotemustine is a nitrosourea compound used for the treatment of malignant gliomas, especially in France. Recently, an EORTC-NCIC study has shown that a concomitant combination of radiotherapy plus temozolomide （an oral cytotoxic drug） improved survival in glioblastoma patients. We set out to test a concurrent combination of radiotherapy and fotemustine for newly malignant gliomas.
出处
《中国神经肿瘤杂志》
2009年第2期109-109,共1页
Chinese Journal of Neuro-Oncology
